Get Wegovy Covered by Aetna in Texas: PA Guide

Aetna's coverage of Wegovy varies by plan type, employer contract, and the specific formulary your group policy uses. On fully insured commercial plans where Aetna controls the formulary, Wegovy is most commonly placed on Tier 4 or Tier 5 (specialty tier), which means it is covered but requires prior authorization before a pharmacy will dispense it.

Aetna Medicare Advantage plans generally do not cover weight-loss drugs because Medicare Part D was prohibited from covering anti-obesity medications until the Treat and Reduce Obesity Act provisions began taking effect, check your specific plan's Evidence of Coverage for 2025-2026 updates. Medicaid plans administered by Aetna (such as Texas Medicaid) have limited GLP-1 coverage for obesity alone; coverage is more likely when semaglutide is prescribed for Type 2 diabetes under the Ozempic indication.

Self-insured employer plans administered by Aetna (ASO plans) are the most variable category. The employer, not Aetna, decides whether to include or carve out obesity medications. If your HR benefits portal shows 'weight management drugs excluded,' your employer has opted out regardless of Aetna's standard formulary. In that case, the savings card and compounded alternatives discussed below become your primary options.

If your Aetna card shows a group number starting with common commercial prefixes and you have a plan year that renewed after January 2024, the odds of coverage are meaningfully higher than they were two or three years ago. Confirm your benefit by calling the member number on your card and asking specifically: 'Is Wegovy, NDC 0169-4151-12, covered under my plan and what tier is it on?'

Aetna's clinical policy bulletin for anti-obesity medications (Policy No. 0619) outlines the medical criteria your provider must document when requesting prior authorization for Wegovy. Meeting every criterion on the list before submission significantly reduces the risk of an initial denial.

BMI Threshold You must have a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with at least one obesity-related comorbidity. Qualifying comorbidities include: - Hypertension (diagnosed or treated) - Type 2 diabetes or pre-diabetes - Dyslipidemia (elevated LDL, low HDL, or elevated triglycerides) - Obstructive sleep apnea (diagnosed by sleep study) - Cardiovascular disease (history of heart attack, stroke, or coronary artery disease)

BMI must be documented in the medical record at the time of the request. Aetna requires ICD-10 codes Z68.30 through Z68.45 to capture the specific BMI range, and E66.9 (obesity, unspecified) or E66.01 (morbid obesity) to confirm the obesity diagnosis. Your provider must include both the BMI code and the obesity diagnosis code on the prior auth form.

Prior Diet and Exercise Program Aetna requires documentation that the patient has participated in a structured diet and exercise program for at least three consecutive months within the prior two years. 'Structured' means a formal program with documented counseling, not self-reported attempts. This can be documented by a registered dietitian, a physician-supervised program, a commercial weight-loss program (Weight Watchers, Jenny Craig), or a hospital-based medically supervised program. The chart note must include dates, provider name, and measurable outcomes (weight log, calorie targets, exercise prescriptions).

Prescriber Credentials On certain Aetna plan types, particularly older employer group contracts, the prescribing physician must hold an MD or DO credential. Some plans do not accept prior auth requests initiated by nurse practitioners or physician assistants as the ordering provider, though an NP/PA may see you and have an MD co-sign. Confirm with your clinic whether the physician of record on the PA form holds an MD or DO designation.

Other Documentation Requirements - Current weight and height in the chart note - Starting body weight and treatment goal - Absence of contraindications (personal or family history of medullary thyroid carcinoma, MEN2 syndrome, active pancreatitis, pregnancy) - Attestation that the patient has not had a prior trial of semaglutide or liraglutide that was discontinued for non-compliance

Approvals, when granted, are typically for 6 months initially, with a continuation authorization required. Continuation criteria usually include documented weight loss of at least 5% of baseline body weight.

The approval rate for Wegovy prior authorizations improves substantially when the request is submitted with complete documentation the first time. Here is a practical checklist for Houston patients working with their provider.

Before Your Appointment 1. Download your Explanation of Benefits or call Aetna member services to confirm Wegovy is on your formulary (ask for NDC 0169-4151-12 specifically). 2. Pull together records from any diet or exercise program you have participated in over the past two years. If you used a registered dietitian, ask for a visit summary. If you attended a hospital program, request a letter on letterhead. 3. Get your most recent BMI-containing visit note from your primary care provider, ideally within 90 days.

At Your Provider Visit 1. Ask your provider to include the following in the chart note: current BMI with ICD-10 Z68.xx code, obesity diagnosis with E66.9 or E66.01, a documented discussion of the obesity-related comorbidity that qualifies you (if BMI is 27-29.9), and explicit notation of the prior structured weight-loss attempt. 2. Confirm the PA form will list an MD or DO as the ordering provider. 3. Request that the office send the PA with supporting chart notes attached, not just the form alone.

After Submission Aetna must respond to a standard prior auth within 15 days for non-urgent requests, or 72 hours for urgent requests. Call your provider's office after 10 business days if you have not heard anything. Delays are often caused by missing documentation rather than a denial decision. A prior auth coordinator at your clinic can call Aetna provider services to request a pend status and identify any outstanding information.

A denial letter from Aetna is not the end of the road. Roughly one-third of denied prior authorizations for specialty medications are reversed at the first level of appeal. The key is acting within the appeal window and escalating systematically.

Step 1: Read the Denial Reason Carefully Aetna's denial letter will cite the specific clinical criterion that was not met. Common denial reasons include: 'insufficient documentation of prior diet/exercise program,' 'BMI documentation not in clinical record,' or 'not medically necessary.' The denial reason tells you exactly what to fix or rebut.

Step 2: Peer-to-Peer Review This is the fastest and often most effective step. Your physician (specifically the MD or DO on the claim) can call Aetna's medical director to discuss the clinical rationale. This is called a peer-to-peer review and must typically be requested within 14 days of the denial. Ask your provider's office to request a peer-to-peer call with Aetna's regional medical director. Physicians often report success in these conversations when they can speak directly to the patient's comorbidities and document why other interventions have been insufficient. This call does not count as a formal appeal and can happen before you file written paperwork.

Step 3: First-Level Internal Appeal If the peer-to-peer does not resolve the denial, file a formal first-level appeal. You have 180 days from the denial date on most Aetna plans. Include: - A written letter of medical necessity from your physician - Peer-reviewed literature supporting semaglutide for your documented BMI/comorbidity combination (the SELECT trial data showing cardiovascular benefit is particularly useful if you have existing CVD) - All documentation you believe was missing from the original request - Copies of your diet/exercise program records

Step 4: Second-Level Internal Appeal or External Review If the first-level appeal is denied, you can request a second-level internal review (some plans require this) or go directly to an Independent Review Organization (IRO) for an external appeal. Under the Affordable Care Act, you have the right to an external review by an independent organization not affiliated with Aetna.

Step 5: Texas Department of Insurance Complaint If your plan is a fully insured (not self-insured) plan in Texas, you can file a complaint with the Texas Department of Insurance (TDI) at tdi.texas.gov. TDI can require Aetna to reconsider the denial. Self-insured employer plans are regulated by the federal Department of Labor rather than TDI, so the complaint goes to the DOL's Employee Benefits Security Administration instead.

Timeline Note: Do not wait on an appeal if you want to start treatment. Ask your Houston weight loss clinic about the savings card option or compounded semaglutide as a bridge while the appeal is in process.

Even without insurance approval, Novo Nordisk offers the Wegovy Together savings program for patients who have commercial insurance but whose plan does not cover Wegovy, or who are facing high cost-sharing.

Under the current program terms, eligible patients with commercial insurance (not Medicare or Medicaid) pay as little as $0 to $25 per month for Wegovy for up to 24 months. The savings card applies at the pharmacy and is renewed automatically. Patients can enroll at WegovyTogether.com or ask their provider's office to submit enrollment during the prior auth process.

Who qualifies: - Must have commercial insurance (including ACA marketplace plans) - Cannot be enrolled in Medicare, Medicaid, or any federal health care program - Must be a U.S. resident - Income limits may apply; check the current program terms as Novo Nordisk has modified the program several times since 2023

Who does not qualify: - Medicare Part D beneficiaries - Texas Medicaid members - Uninsured patients (a separate Novo Nordisk patient assistance program exists for very low-income uninsured patients, ask your pharmacist)

Aetna members whose employer plan excludes obesity medications entirely are still eligible for the savings card as long as they meet the commercial insurance criteria above. This makes the savings card a practical option while pursuing a plan amendment or coverage appeal with your HR department.

During periods when branded Wegovy has faced supply shortages, the FDA has permitted FDA-registered 503B outsourcing facilities and licensed compounding pharmacies to produce compounded semaglutide, which does not carry Novo Nordisk's brand or its savings card, but is significantly less expensive.

Many Houston weight loss clinics offer compounded semaglutide at $199 to $350 per month, typically dispensed as subcutaneous injections with the same titration schedule as Wegovy. Because this is a compounded preparation, it is not FDA-approved and is not eligible for insurance reimbursement under most plans.

Important caveats as of mid-2026: - The FDA's enforcement posture on compounded semaglutide has shifted. After Wegovy was removed from the FDA's shortage list in late 2024, many compounding pharmacies were required to wind down production. Availability through Houston clinics varies, confirm with each clinic whether they are currently sourcing from an FDA-registered 503B facility. - Compounded semaglutide is a reasonable short-term option if you are waiting on a prior auth appeal, but the long-term cost and regulatory picture differs from branded Wegovy. - Clinical trial data (including the STEP trials and the SELECT cardiovascular outcomes trial) used branded semaglutide 2.4 mg. Compounded versions have not been independently studied in large trials.

Discuss the current legal and clinical status of compounded semaglutide with your Houston provider before committing to that route.

Navigating prior authorization for a specialty medication is easier when your clinic has dedicated staff who handle PA submissions regularly. Houston has a growing number of weight loss clinics and obesity medicine physicians, some specialize in insurance navigation and can handle Aetna prior auths as part of their standard intake process.

When evaluating a Houston weight loss clinic for Aetna coverage, ask the following questions before scheduling:

1. Does the clinic accept Aetna insurance? Verify that the prescribing physician is in-network on your specific Aetna plan. Out-of-network provider visits may not satisfy Aetna's requirement that the prescriber be a participating provider on some PA forms. 2. Does the clinic submit prior authorizations for Wegovy in-house? Some clinics outsource PA work or leave it entirely to the patient. A clinic with a dedicated PA coordinator handles the documentation burden and typically has better approval rates because they know what Aetna reviewers look for. 3. Does the clinic maintain a registered dietitian or structured diet program on-site? On-site diet counseling can satisfy Aetna's 3-month structured program requirement going forward, and provides documentation if a renewal PA is needed. 4. Is the prescribing physician an MD or DO? As noted above, some Aetna plan types require this. Confirm before your first visit. 5. What is the clinic's process if Aetna denies the initial request? Clinics with experience in appeals can initiate the peer-to-peer call on your behalf, draft the letter of medical necessity, and submit the formal appeal within the required window.

The Houston Weight Loss Directory lists clinics by neighborhood and includes information on insurance accepted. Filtering by 'Aetna' and 'Wegovy' can narrow your options to providers already familiar with the prior authorization process in your part of the city.